These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
930 related articles for article (PubMed ID: 26091825)
1. Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system. Pico de CoaƱa Y; Choudhury A; Kiessling R Trends Mol Med; 2015 Aug; 21(8):482-91. PubMed ID: 26091825 [TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy. McArthur HL; Page DB Clin Adv Hematol Oncol; 2016 Nov; 14(11):922-933. PubMed ID: 27930644 [TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitor combinations in solid tumors: opportunities and challenges. Kyi C; Postow MA Immunotherapy; 2016 Jun; 8(7):821-37. PubMed ID: 27349981 [TBL] [Abstract][Full Text] [Related]
4. Immune Checkpoint Inhibitors in Organ Transplant Patients. Kittai AS; Oldham H; Cetnar J; Taylor M J Immunother; 2017 Sep; 40(7):277-281. PubMed ID: 28719552 [TBL] [Abstract][Full Text] [Related]
5. Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs. Allard B; Pommey S; Smyth MJ; Stagg J Clin Cancer Res; 2013 Oct; 19(20):5626-35. PubMed ID: 23983257 [TBL] [Abstract][Full Text] [Related]
6. Immune Checkpoint Therapy in Melanoma. Callahan MK Cancer J; 2016; 22(2):73-80. PubMed ID: 27111901 [TBL] [Abstract][Full Text] [Related]
8. The evolution of checkpoint blockade as a cancer therapy: what's here, what's next? Shin DS; Ribas A Curr Opin Immunol; 2015 Apr; 33():23-35. PubMed ID: 25621841 [TBL] [Abstract][Full Text] [Related]
9. Immune Checkpoint Inhibitors in the Treatment of Gynecologic Malignancies. Ring KL; Pakish J; Jazaeri AA Cancer J; 2016; 22(2):101-7. PubMed ID: 27111905 [TBL] [Abstract][Full Text] [Related]
10. Immune Checkpoint Therapy in Head and Neck Cancers. Msaouel P; Massarelli E Cancer J; 2016; 22(2):108-16. PubMed ID: 27111906 [TBL] [Abstract][Full Text] [Related]
11. Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells. John LB; Devaud C; Duong CP; Yong CS; Beavis PA; Haynes NM; Chow MT; Smyth MJ; Kershaw MH; Darcy PK Clin Cancer Res; 2013 Oct; 19(20):5636-46. PubMed ID: 23873688 [TBL] [Abstract][Full Text] [Related]
13. Immune Checkpoint Inhibitors. Haanen JB; Robert C Prog Tumor Res; 2015; 42():55-66. PubMed ID: 26382943 [TBL] [Abstract][Full Text] [Related]
14. Combination therapy with anti-CTLA-4 and anti-PD-1 leads to distinct immunologic changes in vivo. Das R; Verma R; Sznol M; Boddupalli CS; Gettinger SN; Kluger H; Callahan M; Wolchok JD; Halaban R; Dhodapkar MV; Dhodapkar KM J Immunol; 2015 Feb; 194(3):950-9. PubMed ID: 25539810 [TBL] [Abstract][Full Text] [Related]
15. Combined Radiation Therapy and Immune Checkpoint Blockade Therapy for Breast Cancer. Hu ZI; Ho AY; McArthur HL Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):153-164. PubMed ID: 28816141 [TBL] [Abstract][Full Text] [Related]
16. Development of Cancer Immunotherapy Targeting the PD-1 Pathway. Kamimura N; Wolf AM; Iwai Y J Nippon Med Sch; 2019; 86(1):10-14. PubMed ID: 30918149 [TBL] [Abstract][Full Text] [Related]
17. Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy. Rojas JJ; Sampath P; Hou W; Thorne SH Clin Cancer Res; 2015 Dec; 21(24):5543-51. PubMed ID: 26187615 [TBL] [Abstract][Full Text] [Related]
18. Immune Checkpoint Therapies in Prostate Cancer. Goswami S; Aparicio A; Subudhi SK Cancer J; 2016; 22(2):117-20. PubMed ID: 27111907 [TBL] [Abstract][Full Text] [Related]
20. Novel approaches in cancer immunotherapy -- a light at the end of the tunnel. Joshi M; Pal SK; Drabick JJ Discov Med; 2016 Jun; 21(118):479-87. PubMed ID: 27448784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]